Influence of obesity on breast cancer receptor status and prognosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Pre-existing obesity and postoperative weight gain are related to a poor prognosis in breast cancer regardless of menopausal status. Delayed diagnosis may be one cause, but of more biological significance, especially in younger women, is the association of adiposity with estrogen receptor-negative tumors with a propensity for distant metastasis. After the menopause, the major mechanism for the relationship is the elevated estrogen synthesis by adipose tissue; these hormone-dependent tumors are estrogen receptor-positive. Insulin and some adipokines also stimulate breast cancer growth and metastasis, both directly and most probably by enhanced angiogenesis. Weight control is important, not only to target breast cancer progression, but also to reduce the risk of nonbreast cancer mortality risk associated with excess adiposity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Triple-negative breast cancer: clinical features and patterns of recurrence
Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Vona-Davis, L., & Rose, D. P. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-06-0068 · Cited by 496
Self-citationObesity, adipocytokines, and insulin resistance in breast cancer
Rose, D. P., Komninou, D., & Stephenson, G. D. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00142.x · Cited by 460
Self-citation
Research works printed but not linked: 68
- Bianchini, 2002, Lancet Oncol., 3, 565, 10.1016/S1470-2045(02)00849-5 · DOI · Paper page
- Vona-Davis, 2007, Obes. Rev., 8, 395, 10.1111/j.1467-789X.2007.00396.x · DOI · Paper page
- 10.1207/S15327914NC4501_1 · DOI · Paper page
- Bentzon, 2008, Int. J. Cancer, 122, 1089, 10.1002/ijc.22892 · DOI · Paper page
- Bauer, 2007, Cancer, 109, 1721, 10.1002/cncr.22618 · DOI · Paper page
- Vona-Davis, 2008, Cancer Epidemiol. Biomarkers Prev., 17, 3319, 10.1158/1055-9965.EPI-08-0544 · DOI
- Chang, 2008, Obesity (Silver Spring), 16, 1636, 10.1038/oby.2008.228 · DOI
- Chlebowski, 2002, J. Clin. Oncol., 20, 1128, 10.1200/JCO.20.4.1128 · doi:10.1200/jco.20.4.1128 · Paper page
- Berclaz, 2004, Ann. Oncol., 15, 875, 10.1093/annonc/mdh222 · DOI · Paper page
- Whiteman, 2005, Cancer Epidemiol. Biomarkers Prev., 14, 2009, 10.1158/1055-9965.EPI-05-0106 · DOI · Paper page
- Cleveland, 2005, Cancer Epidemiol. Biomarkers Prev., 16, 1803, 10.1158/1055-9965.EPI-06-0889 · DOI · Paper page
- Chang, 1998, J. Clin. Oncol., 6, 3731, 10.1200/JCO.1998.16.12.3731 · DOI
- Chang, 2000, Breast Cancer Res. Treat., 64, 157, 10.1023/A:1006489100283 · DOI
- Enger, 2007, Arch. Surg., 139, 954, 10.1001/archsurg.139.9.954 · DOI · Paper page
- 10.1207/S15327914NC4402_02 · DOI · Paper page
- Huang, 1999, Am. J. Epidemiol., 150, 1316, 10.1093/oxfordjournals.aje.a009963 · DOI · Paper page
- Olson, 2006, J. Womens Health (Larchmt), 15, 836, 10.1089/jwh.2006.15.836 · DOI
- Goodwin, 2009, Breast Cancer Res. Treat., 114, 517, 10.1007/s10549-008-0019-0 · DOI
- Borugian, 2003, Am. J. Epidemiol., 158, 963, 10.1093/aje/kwg236 · DOI · Paper page
- Maehle, 2004, APMIS, 112, 349, 10.1111/j.1600-0463.2004.apm1120605.x · DOI
- Porter, 2006, Ann. Surg. Oncol., 13, 327, 10.1245/ASO.2006.03.049 · DOI
- Daling, 2001, Cancer, 92, 720, 10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T · DOI · Paper page
- Hunt, 2000, AJR Am. J. Roentgenol., 174, 1251, 10.2214/ajr.174.5.1741251 · DOI
- Rose, 2001, Cancer Detect. Prev., 25, 16
- Rose, 2007, Endocr. Rev., 28, 763, 10.1210/er.2006-0019 · DOI · Paper page
- Cui, 2002, J. Womens Health Gend. Based Med., 11, 527, 10.1089/152460902760277886 · DOI
- Porter, 2004, Cancer, 100, 2533, 10.1002/cncr.20279 · DOI
- Borgquist, 2009, Int. J. Cancer, 124, 402, 10.1002/ijc.23850 · doi:10.1002/ijc.23850
- Oestreicher, 2004, Breast Cancer Res. Treat., 85, 133, 10.1023/B:BREA.0000025402.70958.3e · DOI
- Gentili, 1981, Cancer, 48, 974, 10.1002/1097-0142(19810815)48:4<974::AID-CNCR2820480420>3.0.CO;2-# · doi:10.1002/1097-0142(19810815)48:4<974::aid-cncr2820480420>3.0.co;2-#
- McGurrin, 1987, Cancer, 59, 1744, 10.1002/1097-0142(19870515)59:10<1744::AID-CNCR2820591012>3.0.CO;2-D · DOI
- Demirkan, 2007, Jpn. J. Clin. Oncol., 37, 256, 10.1093/jjco/hym023 · DOI
- Loi, 2005, Cancer Epidemiol. Biomarkers Prev., 14, 1686, 10.1158/1055-9965.EPI-05-0042 · DOI · Paper page
- Silha, 2005, Int. J. Obes. (Lond.), 29, 1308, 10.1038/sj.ijo.0802987 · DOI · Paper page
- Dawood, 2008, Clin. Cancer Res., 14, 1718, 10.1158/1078-0432.CCR-07-1479 · DOI · Paper page
- Amend, 2006, Cancer Res., 66, 8327, 10.1158/0008-5472.CAN-06-1927 · DOI · Paper page
- Rosenberg, 2006, Cancer Epidemiol. Biomarkers Prev., 15, 2482, 10.1158/1055-9965.EPI-06-0489 · DOI · Paper page
- Suzuki, 2006, Int. J. Cancer, 119, 1683, 10.1002/ijc.22034 · DOI · Paper page
- Colditz, 2004, J. Natl Cancer Inst., 96, 218, 10.1093/jnci/djh025 · DOI · Paper page
- Huang, 2000, Am. J. Epidemiol., 151, 703, 10.1093/oxfordjournals.aje.a010265 · DOI · Paper page
- Enger, 2000, Cancer Epidemiol. Biomarkers Prev., 9, 681
- Suzuki, 2009, Int. J. Cancer, 124, 698, 10.1002/ijc.23943 · DOI · Paper page
- Kyndi, 2008, J. Clin. Oncol., 26, 1419, 10.1200/JCO.2007.14.5565 · DOI · Paper page
- Gajdos, 2000, J. Am. Coll. Surg., 190, 523, 10.1016/S1072-7515(00)00257-X · DOI · Paper page
- Hess, 2003, Breast Cancer Res. Treat., 78, 105, 10.1023/A:1022166517963 · DOI · Paper page
- Reis-Filho, 2008, Histopathology, 52, 108, 10.1111/j.1365-2559.2007.02889.x · DOI · Paper page
- Haffty, 2006, J. Clin. Oncol., 24, 5652, 10.1200/JCO.2006.06.5664 · DOI · Paper page
- Dent, 2008, Breast Cancer Res. Treat., 115, 423, 10.1007/s10549-008-0086-2 · DOI · Paper page
- Millikan, 2008, Breast Cancer Res. Treat., 109, 123, 10.1007/s10549-007-9632-6 · DOI · Paper page
- Key, 2002, J. Natl Cancer Inst., 94, 606, 10.1093/jnci/94.8.606 · DOI · Paper page
- Feigelson, 2004, Cancer Epidemiol. Biomarkers Prev., 13, 220, 10.1158/1055-9965.EPI-03-0301 · DOI · Paper page
- De Pergola, 2006, Obesity (Silver Spring), 14, 1954, 10.1038/oby.2006.228 · DOI
- Goodwin, 2002, J. Clin. Oncol., 20, 42, 10.1200/JCO.20.1.42 · doi:10.1200/jco.20.1.42 · Paper page
- Borugian, 2004, Cancer Epidemiol. Biomarkers Prev., 13, 1163, 10.1158/1055-9965.1163.13.7 · DOI · Paper page
- Kerbel, 2008, N. Engl. J. Med., 358, 2039, 10.1056/NEJMra0706596 · DOI · Paper page
- Fain, 2005, Metabolism, 54, 220, 10.1016/j.metabol.2004.08.016 · DOI
- Bermont, 2001, J. Clin. Endocrinol. Metab., 86, 363
- Shrader, 2009, Arch. Dermatol. Res., 301, 159, 10.1007/s00403-008-0921-7 · DOI
- Ishikawa, 2004, Clin. Cancer Res., 10, 4325, 10.1158/1078-0432.CCR-03-0749 · DOI · Paper page
- Liu, 2007, Oncology, 72, 75, 10.1159/000111097 · doi:10.1159/000111097
- Ligibel, 2008, J. Clin. Oncol., 26, 907, 10.1200/JCO.2007.12.7357 · DOI · Paper page
- Kroenke, 2005, J. Clin. Oncol., 23, 1370, 10.1200/JCO.2005.01.079 · DOI · Paper page
- Griggs, 2005, Arch. Intern. Med., 165, 1267, 10.1001/archinte.165.11.1267 · DOI · Paper page
- Dignam, 2003, J. Natl Cancer Inst., 95, 1467, 10.1093/jnci/djg060 · DOI · Paper page
- Goodwin, 2008, Clin. Breast Cancer, 8, 501, 10.3816/CBC.2008.n.060 · DOI · Paper page
- Chlebowski, 2006, J. Natl Cancer Inst., 98, 1767, 10.1093/jnci/djj494 · DOI · Paper page
- Dignam, 2006, Breast Cancer Res. Treat., 97, 245, 10.1007/s10549-005-9118-3 · DOI
- Braithwaite, 2009, Int. J. Cancer, 124, 1213, 10.1002/ijc.24054 · DOI
Cited by
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
Ewertz, M., Jensen, M.-B., Gunnarsdóttir, K. Á., Højris, I., Jakobsen, E. H., Nielsen, D., Stenbygaard, L. E., Tange, U. B., & Cold, S. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7614 · Cited by 592
Morris, P. G., Hudis, C. A., Giri, D., Morrow, M., Falcone, D. J., Zhou, X. K., Du, B., Brogi, E., Crawford, C. B., Kopelovich, L., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0110 · Cited by 465
Obesity and cancer: inflammation bridges the two
Kolb, R., Sutterwala, F. S., & Zhang, W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.005 · Cited by 405
Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland
Subbaramaiah, K., Howe, L. R., Bhardwaj, P., Du, B., Gravaghi, C., Yantiss, R. K., Zhou, X. K., Blaho, V. A., Hla, T., Yang, P., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0381 · Cited by 363
Retracted
Metadata
- Authors
- Rose, D. P., & Vona-Davis, L.
- Venue
- Expert Review of Anticancer Therapy
- Publisher
- Informa UK Limited
- Published
- 2009-08
- Volume
- 9
- Issue
- 8
- Pages
- 1091-1101
- ISSN
- 1473-7140 (ISSN-L)
- 1744-8328
- OpenAlex
- W2020938980
- Cited by
- 71
- References
- 3
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Influence of obesity on breast cancer receptor status and prognosis. https://app.cochat.ai/papers/10.1586/era.09.71
- The paper
- Rose, D. P., & Vona-Davis, L. (2009). Influence of obesity on breast cancer receptor status and prognosis. Expert Review of Anticancer Therapy. https://doi.org/10.1586/era.09.71
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.